Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 30/100

Failure Rate

14.1%

38 terminated/withdrawn out of 270 trials

Success Rate

84.5%

-2.0% vs industry average

Late-Stage Pipeline

49%

132 trials in Phase 3/4

Results Transparency

65%

134 of 207 completed trials have results

Key Signals

7 recruiting134 with results28 terminated10 withdrawn

Enrollment Performance

Analytics

Phase 3

92(36.1%)

Phase 2

55(21.6%)

Phase 1

43(16.9%)

Phase 4

40(15.7%)

N/A

24(9.4%)

Early Phase 1

1(0.4%)

255Total

Phase 3(92)

Phase 2(55)

Phase 1(43)

Phase 4(40)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (270)

Showing 20 of 270 trials

NCT07428538Phase 3Recruiting

Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

Role: lead

NCT07524946Phase 4Not Yet Recruiting

Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo

Role: lead

NCT03988439Phase 4Completed

A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis

Role: lead

NCT07205107Active Not Recruiting

Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris

Role: lead

NCT07285785Phase 4Recruiting

Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea

Role: lead

NCT07214272Not ApplicableActive Not Recruiting

A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing

Role: lead

NCT03596905Phase 2Completed

Efficacy and Safety of Plecanatide in Children 6 to <18 Years With Irritable Bowel Syndrome With Constipation (IBS-C)

Role: lead

NCT05582434Early Phase 1Active Not Recruiting

Experience With Topical Acne Treatment

Role: collaborator

NCT07187297Not ApplicableRecruiting

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

Role: lead

NCT05608499Phase 3Terminated

Duobrii Treatment of Acne Keloidalis Nuchae (AKN)

Role: collaborator

NCT04892706Phase 2Completed

Study to Compare the Safety and Efficacy of IDP-126 Gel to Epiduo® Forte Gel and Vehicle Gel

Role: lead

NCT05132231Active Not Recruiting

Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work Productivity

Role: lead

NCT05976802Phase 4Not Yet Recruiting

Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis

Role: lead

NCT02129751Phase 4Not Yet Recruiting

Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder

Role: lead

NCT04356677Phase 1Withdrawn

Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19_#2

Role: lead

NCT03240809Phase 4Active Not Recruiting

An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects

Role: lead

NCT04314375Phase 4Recruiting

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Role: lead

NCT00568997Active Not Recruiting

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

Role: lead

NCT03254667Enrolling By Invitation

LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis

Role: lead

NCT05297448Phase 3Active Not Recruiting

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

Role: lead